CEL-SCI CFO granted 225,000 stock options at $1.49
CEL SCI CORP Chief Financial Officer Patricia B. Prichep received a grant of stock options covering 225,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CEL SCI CORP Chief Financial Officer Patricia B. Prichep received a grant of stock options covering 225,000 shares of common stock. The options have an exercise price of $1.49 per share, a reported transaction price of $0.01 per option, and expire on August 13, 2036. They vest in three equal annual installments beginning one year after the grant date. Following this award, she holds 299,693 options in total.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options F1 | 225,000 | $0.01 | $2K |
Footnotes (1)
- F1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.
Key Figures
Key Terms
stock options financial
exercise price financial
underlying security financial
Grant, award, or other acquisition financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CVM CFO Patricia Prichep report on this Form 4?
What is the exercise price of the new CEL SCI (CVM) options granted to the CFO?
When do Patricia Prichep’s new CVM stock options vest?
When do the newly granted CEL SCI (CVM) options to the CFO expire?
How many CEL SCI (CVM) options does the CFO hold after this grant?
What transaction price per option was reported for the new CVM grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.